Effect of the Dysbindin Gene on Antimanic Agents in Patients with Bipolar I Disorder
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: We previously reported an association between dysbindin gene (DTNBP1) variants and bipolar I disorder (BID). This paper expands upon previous findings suggesting that DTNBP1 variants may play a role in the response to acute mood stabilizer treatment. Methods: A total of 45 BID patients were treated with antimanic agents (lithium, valproate, or carbamazepine) for an average of 36.52 (±19.87) days. After treatment, the patients were evaluated using the Clinical Global Impression (CGI) scale and the Young Mania Rating Scale (YMRS) and genotyped for their DTNBP1 variants (rs3213207 A/G, rs1011313 C/T, rs2005976 G/A, rs760761 C/T and rs2619522 A/C). Results: There was no association between the variants investigated and response to mood stabilizer treatment, even after considering possible stratification factors. Conclusion: Although the small number of subjects is an important limitation in our study, DTNBP1 does not seem to be involved in acute antimanic efficacy.
Abstract
Objective: We previously reported an association between dysbindin gene (DTNBP1) variants and bipolar I disorder (BID). This paper expands upon previous findings suggesting that DTNBP1 variants may play a role in the response to acute mood stabilizer treatment. Methods: A total of 45 BID patients were treated with antimanic agents (lithium, valproate, or carbamazepine) for an average of 36.52 (±19.87) days. After treatment, the patients were evaluated using the Clinical Global Impression (CGI) scale and the Young Mania Rating Scale (YMRS) and genotyped for their DTNBP1 variants (rs3213207 A/G, rs1011313 C/T, rs2005976 G/A, rs760761 C/T and rs2619522 A/C). Results: There was no association between the variants investigated and response to mood stabilizer treatment, even after considering possible stratification factors. Conclusion: Although the small number of subjects is an important limitation in our study, DTNBP1 does not seem to be involved in acute antimanic efficacy.
참고문헌 (27)
- Althoff RR, "Family, twin, adoption, and molecular genetic studies of juvenile bipolar disorder", Bipolar Disord, 7, pp.598~609 (2005)
- Savitz JB, "Trends in suicidology: personality as an endophenotype for molecular genetic investigations", PLoS Med, 3, pp.e107~ (2006)
- Malhotra AK, "Pharmacogenetics of psychotropic drug response", Am J Psychiatry, 161, pp.780~796 (2004)
- Savitz J, "Neuropsychological dysfunction in bipolar affective disorder: a critical opinion", Bipolar Disord, 7, pp.216~235 (2005)
- Zhou R, "Identification of molecular mechanisms underlying mood stabilization through genome-wide gene expression profiling", Int J Neuropsychopharmacol, 9, pp.263~266 (2006)
- Benson MA, "Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain", J Biol Chem, 276, pp.24232~24241 (2001)
- Iizuka Y, "Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization", J Neurosci, 27, pp.12390~12395 (2007)
- Amerian Psychiatric Association, "Practice guideline for the treatment of patients with bipolar disorder", Am J Psychiatry, 151, pp.1~36 (1994)
- Kleindienst N, "Psychosocial and demographic factors associated with response to prophylactic lithium: a systematic review for bipolar disorders", Psychol Med, 35, pp.1685~1694 (2005)
- Ruzickova M, "Pharmacogenetics and mood stabilization in bipolar disorder", Am J Med Genet C Semin Med Genet, 123C, pp.18~25 (2003)
- Rowe MK, "Lithium neuroprotection: molecular mechanisms and clinical implications", Expert Rev Mol Med, 6, pp.1~18 (2004)
- Alda M, "Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.1038~1045 (2005)
- Rao JS, "Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2", J Neurochem, 102, pp.1918~1927 (2007)
- Kazuno AA, "Relationships between mitochondrial DNA subhaplogroups and intracellular calcium dynamics", Mitochondrion, 8, pp.164~169 (2008)
- Einat H, "Modelling facets of mania--new directions related to the notion of endophenotypes", J Psychopharmacol, 20, pp.714~722 (2006)
- Kishimoto M, "The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis", Biol Psychiatry, 63, pp.191~196 (2008)
- Duan J, "DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3’ end of the gene", Hum Hered, 64, pp.97~106 (2007)
- Pae CU, "Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy", Pharmacogenet Genomics, 17, pp.69~75 (2007)
- Schwab SG, "Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families", Am J Hum Genet, 72, pp.185~190 (2003)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)" (1994), American Psychiatric Association
- Yildiz-Yesiloglu A, "Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.969~995 (2006)
- Kugaya A, "Sanacora G. Beyond monoamines: glutamatergic function in mood disorders", CNS Spectr, 10, pp.808~819 (2005)
- Abelli M, "The role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder", Curr Drug Targets, 6, pp.607~614 (2005)
- Goodnick PJ, "Anticonvulsants in the treatment of bipolar mania", Expert Opin Pharmacother, 7, pp.401~410 (2006)
- Pae CU, "Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder", Am J Med Genet B Neuropsychiatr Genet, 144B, pp.701~703 (2007)
- Raybould R, "Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1)", Biol Psychiatry, 57, pp.695~701 (2005)
- Zill P, "The dysbindin gene in major depression: an association study", Am J Med Genet B Neuropsychiatr Genet, 129B, pp.55~58 (2004)
